About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT07269886

BIOMARKERS FOR DRUG SELECTION IN DEPRESSION

The study aims to assess whether providing Clinical Decision Support Software (CDSS) information improves the pharmacological response in patients with depression. The CDSS integrates genomic, clinica...

Lead sponsor: Neomente SAS•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Neomente SAS

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Being male or female, aged 18-65.
•2. Having a current DSM-5 diagnosis of non-psychotic Major Depressive Disorder confirmed by SCID.
•3. Having moderate to severe depressive symptoms as measured by the HAM-D-17.
•4. Being indicated for pharmacotherapy for Major Depressive Disorder.
•5. Providing written informed consent (signed and dated).
•\-

Exclusion Criteria

•1. Having a current or past diagnosis of bipolar disorder or psychotic disorders.
•2. Having a moderate to severe substance use disorder within the past six months.
•3. Having active suicidal ideation.
•4. Having a neurocognitive disorder.
•5. Having an unstable or decompensated medical illness likely to confound study outcomes.
•6. Being pregnant or lactating.
•7. Having known contraindications to the indicated antidepressant classes.
•8. Being unable to provide informed consent.
•\-

Related studies

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

NCT07642882 · Fibromyalgia, Depression - Major Depressive Disorder, and more

RECRUITINGPhase 2

Stratified Pharmacological Approaches for Regulating Circuit-Level Effects

NCT07022405 · Depression - Major Depressive Disorder

RECRUITINGPhase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, and more

RECRUITINGPhase 4

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

NCT07478796 · Depression - Major Depressive Disorder, Depressive Episodes

Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression

NCT07422519 · Depression - Major Depressive Disorder, Depression Disorder, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 8, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment79

Start dateAug 2022

Last updatedDec 8, 2025

Condition

Depression - Major Depressive Disorder

Locations shown

Neomente

Buenos Aires

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions